title: Cytochrome c oxidase-associated Leigh syndrome: phenotypic features and pathogenetic speculations.
abstract: Fourteen new cases of cytochrome oxidase (COX)-associated Leigh syndrome (LS) are combined with 20 reported cases to describe the clinical, laboratory, and radiological features of this devastating metabolic condition. Three clinical stages are identified. Most patients have normal neurological development during the first 8-12 months (stage I). Somatic complaints are common, including chronic diarrhea, recurrent vomiting, anorexia, and decelerating body and head growth. The second stage evolves during late infancy and early childhood when motor regression becomes evident. Eye signs, altered breathing patterns, pyramidal, extrapyramidal, and cerebellar signs emerge and sudden clinical deterioration occurs during intercurrent infectious or metabolic stress. The last stage may extend from 2 to 10 years and is manifested by extreme hypotonia, swallowing difficulties and undernutrition. Feeding assistance is necessary and seizures may occur. The CSF lactate concentration is consistently elevated and MRI abnormalities are seen in the subcortical structures. COX deficiency affects most tissues, but is not always generalized. For example, 3 patients with a cardiomyopathy had normal COX activity in cultured skin fibroblasts. Nearly normal amounts of cross-reacting material are present by ELISA and immunoblot analyses. Parental consanguinity has been found in several families, the hereditary pattern is recessive and males are affected more commonly (2:1). The biomolecular abnormality causing COX deficiency in LS is unknown, but the available evidence implicates a nuclear-encoded protein that affects the structure or the stability of the holoenzyme complex.
authors.affiliation: Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY.
authors.forename: R
authors.initials: R
authors.lastname: Van Coster
authors.forename: A
authors.initials: A
authors.lastname: Lombres
authors.forename: D C
authors.initials: DC
authors.lastname: De Vivo
authors.forename: T L
authors.initials: TL
authors.lastname: Chi
authors.forename: W E
authors.initials: WE
authors.lastname: Dodson
authors.forename: S
authors.initials: S
authors.lastname: Rothman
authors.forename: E J
authors.initials: EJ
authors.lastname: Orrechio
authors.forename: W
authors.initials: W
authors.lastname: Grover
authors.forename: G T
authors.initials: GT
authors.lastname: Berry
authors.forename: J F
authors.initials: JF
authors.lastname: Schwartz
mesh_terms: D000293:Adolescent; D000818:Animals; D002417:Cattle; D002648:Child; D002675:Child, Preschool; D030401:Cytochrome-c Oxidase Deficiency; D003576:Electron Transport Complex IV / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D015151:Immunoblotting; D007223:Infant; D007888:Leigh Disease / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008931:Mitochondria, Muscle / Q000201:enzymology; D009132:Muscles / Q000201:enzymology / Q000473:pathology; D009206:Myocardium / Q000276:immunology / Q000473:pathology
chemical_list: D003576:Electron Transport Complex IV